United States · FDA National Drug Code directory

Thiotepa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0143-9292_f18a13d2-83c0-42a1-8980-60b228c23ab9
Product NDC: 0143-9292
Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term: Thiotepa
Labeler: Hikma Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20230929
Source listing expiry: 20261231

Source-listed ingredients

THIOTEPA — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 VIAL in 1 BOX, UNIT-DOSE (0143-9292-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · 0143-9292-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →